HonCode

Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 05-09-2008, 12:09 PM   #1
gdpawel
Senior Member
 
gdpawel's Avatar
 
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
FDA Scraps Helsinki Declaration on Protecting Human Subjects

The FDA formally declared that it will no longer require that clinical trials submitted to the agency to get regulatory approval for a new drug adhere to the Helsinki Declaration.

The new rule, which goes into effect next October, was supported by the drug industry but opposed by numerous public interest, patient advocacy, and consumer groups.

The new rule requires only that trials conducted abroad by drug manufacturers follow good clinical practices (GCP) and include a review and approval by an independent ethics committee.

There's nothing in GCP guidelines that requires patients in the control arm of a trial get access to already proven therapies.

http://www.gooznews.com:80/archives/001052.html

This article explains the significance of the FDA decision.

http://www.nature.com/embor/journal/...l/7400743.html
gdpawel is offline   Reply With Quote
Old 05-13-2008, 08:40 AM   #2
gdpawel
Senior Member
 
gdpawel's Avatar
 
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
Some critics have said that clinicians, consumers and payers need to know whether or not a new treatment is better than other existing comparable treatments, not a (is this better than nothing) placebo.

The trials with people in this instance are ones who ought to be on some sort of medication. So providing them with nothing, rather than an existing drug, is a serious situation.

It's been an ethical question for a long time here in the United States. Some cannot see that anyone would do something so unethical as set up a trial that did not offer the chance at the current standard of therapy versus a new drug.

Being on a placebo for a few months means that a cancer seriously can progress to the point that treatment would no long benefit them. No thanks! I'd skip clinical trials.

There are some medical oncologists utilizing cell-based bio-markers for years in their managment of their cancer patients that feel it is unethical not to use them, as opposed to "trial-and-error" treatment. Science is in the eye of the beholder. If you know something works better than nothing......
gdpawel is offline   Reply With Quote
Old 06-04-2008, 10:22 PM   #3
gdpawel
Senior Member
 
gdpawel's Avatar
 
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
The FDA drops the ball on patient rights

On assignment for the Scientific American, Merrill Goozner traveled to Romsk, Russia on the western edge of Siberia to get their perspective on the issue of major pharmaceutical companies increasingly moving their clinical trials to countries like this one.

http://science-community.sciam.com/b...ghts/570003206
gdpawel is offline   Reply With Quote
Old 06-08-2008, 10:32 PM   #4
Jackie07
Senior Member
 
Jackie07's Avatar
 
Join Date: Jan 2008
Location: "Love never fails."
Posts: 5,801
These are interesting and important news. Thanks for posting.
__________________
Jackie07
http://www.kevinmd.com/blog/2011/06/doctors-letter-patient-newly-diagnosed-cancer.html
http://www.asco.org/ASCOv2/MultiMedi...=114&trackID=2

NICU 4.4 LB
Erythema Nodosum 85
Life-long Central Neurocytoma 4x5x6.5 cm 23 hrs 62090 semi-coma 10 d PT OT ST 30 d
3 Infertility tmts 99 > 3 u. fibroids > Pills
CN 3 GKRS 52301
IDC 1.2 cm Her2 +++ ER 5% R. Lmptmy SLNB+1 71703 6 FEC 33 R Tamoxifen
Recc IIB 2.5 cm Bi-L Mast 61407 2/9 nds PET
6 TCH Cellulitis - Lymphedema - compression sleeve & glove
H w x 4 MUGA 51 D, J 49 M
Diastasis recti
Tamoxifen B. scan
Irrtbl bowel 1'09
Colonoscopy 313
BRCA1 V1247I
hptc hemangioma
Vertigo
GI - > yogurt
hysterectomy/oophorectomy 011410
Exemestane 25 mg tab 102912 ~ 101016 stopped due to r. hip/l.thigh pain after long walk
DEXA 1/13
1-2016 lesions in liver largest 9mm & 1.3 cm onco. says not cancer.
3-11 Appendectomy - visually O.K., a lot of puss. Final path result - not cancer.
Start Vitamin D3 and Calcium supplement (600mg x2)
10-10 Stopped Exemestane due to r. hip/l.thigh pain OKed by Onco 11-08-2016

"I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY." Irene from Tampa

Advocacy is a passion .. not a pastime - Joe
Jackie07 is offline   Reply With Quote
Old 02-05-2009, 07:20 PM   #5
gdpawel
Senior Member
 
gdpawel's Avatar
 
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
Pharma Co. Accused of Running Unethical Trials in India

GoozNews reported that the Dutch non-profit Wemos International, which works to protect human subjects in clinical trials, accused GlaxoSmithKline of having run a breast cancer trial in India that violated international norms on protecting human subjects.

The trial involved Tykerb (lapatinib), which had been approved in the United States for woman stricken with breast tumors that overexpress the Her2 gene. The NGO's press release suggested Indian women could not offer meaningful informed consent to participate in the trial since it was the only way for most Indian women to gain access to the drug.

The Wemos report also accused AstraZeneca of running a trial for a schizophrenia drug that used placebos in the comparison arm when other approved treatments were available.

The U.S. withdrew from the Helsinki Declaration, which prohibits placebo-controlled clinical trials to test new drugs for serious or life-threatening diseases when other effective therapies are already available.

http://www.wemos.nl/en-GB/Content.as...e=news&id=3095
gdpawel is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 02:42 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2018, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter